isomethyleugenol has been researched along with B-Cell Lymphoma in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (35.00) | 18.2507 |
2000's | 4 (20.00) | 29.6817 |
2010's | 7 (35.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Creighton, JH; Fesik, SW; Flaherty, DK; Florian, AC; Howard, GC; Liu, Q; Lorey, SL; Matlock, BK; Siladi, AJ; Tansey, WP; Thomas, LR; Wang, J; Weissmiller, AM | 1 |
Alinari, L; Baiocchi, RA; Chung, J; Karkhanis, V; Ozer, HG; Sif, S; Zhang, X | 1 |
Aparicio, SA; Berg, T; Bilenky, M; Chang, H; Cheng, SW; Gascoyne, RD; Hirst, M; Humphries, RK; Lai, CK; Lai, D; Lee, S; Lim, E; Marra, MA; Morin, GB; Morin, RD; Mungall, AJ; Oellerich, T; Rosten, P; Salmi, A; Schoeler, N; Serve, H; Thoene, S; Umlandt, P; Wee, T; Yap, D; Yue, L | 1 |
Bradner, JE; Burd, CE; Clark, KS; Fedoriw, Y; Jeck, WR; Liu, JY; Parker, JS; Paulk, J; Qi, J; Sharpless, NE; Simon, JM; Souroullas, GP; Xiong, J | 1 |
Charlier, C; Georges, M; Jarosova, M; Katrincsakova, B; Michaux, L; Takeda, H; Urbankova, H; Vandenberghe, P; Wlodarska, I | 1 |
Copeland, RA; Knutson, SK; Kuntz, KW; Pollock, RM; Richon, VM; Scott, MP; Sneeringer, CJ | 1 |
Allen, KE; Brandt, M; Chen, SB; Creasy, CL; Della Pietra, A; Diaz, E; Dul, E; Ganji, G; Gilbert, SA; Graves, AP; Halsey, WS; Hughes, AM; Jiang, Y; Kruger, RG; McCabe, MT; Ott, HM; Pappalardi, MB; Schwartz, B; Smitheman, KN; Thrall, SH; Tummino, PJ | 1 |
Bai, M; Bower, M; Briasoulis, E; Crook, T; Dasoula, A; Dyer, MJ; ElguetaKarstegl, C; Farrell, PJ; Hatzimichael, E; Janczar, K; Karran, LE; Lattanzio, L; Lo Nigro, C; Merlano, M; Monteverde, M; Papoudou-Bai, A; Schmid, P; Shah, R; Stebbing, J; Syed, N; Thompson, A; Vivenza, D | 1 |
Chen, Z; Dou, Y; Viboolsittiseri, SS; Wang, JH; Yan, CT | 1 |
Bhalla, K; Chan, JC; Chen-Kiang, S; Dalton, WS; Fiskus, W; Fu, K; Lin, J; Lwin, T; Marquez, VE; Moscinski, LC; Rao, R; Seto, E; Sotomayor, E; Tao, J; Wright, KL; Zhang, X; Zhang, Y; Zhao, X | 1 |
Fitzgibbon, J; Joel, S; Last, K; Lister, TA; Maharaj, L; Perry, J; Strauss, S | 1 |
Ambinder, RF; Barletta, J; Robertson, KD; Samid, D | 1 |
Berinstein, NL; Stiernholm, NB | 1 |
Gottschalk, AR; Joseph, LJ; Quintáns, J | 1 |
Ambinder, RF; Gulley, ML; Manns, A; Robertson, KD; Swinnen, LJ; Zong, JC | 1 |
Ambinder, RF; Robertson, KD; Srivastava, G; Swinnen, LJ; Tao, Q; Yang, J | 1 |
Algara, P; Camacho, F; Navas, IC; Piris, MA; Sáez, AI; Sánchez, E; Sánchez-Aguilera, A; Sánchez-Beato, M; Sol Mateo, M; Villuendas, R | 1 |
Doyle, M; Jenuwein, T; Kohlmaier, A; Lachner, M; Mechtler, K; O'Carroll, D; Opravil, S; Pagani, M; Peters, AH; Sauer, S; Scherthan, H; Schöfer, C; Sibilia, M; Weipoltshammer, K | 1 |
Basham, TY; Merigan, TC; Reid, TR | 1 |
Kessler, DJ; La Rosa, FA; Sonenshein, GE; Spicer, DB | 1 |
20 other study(ies) available for isomethyleugenol and B-Cell Lymphoma
Article | Year |
---|---|
WIN site inhibition disrupts a subset of WDR5 function.
Topics: Antineoplastic Agents; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatin Assembly and Disassembly; Gene Expression Regulation, Neoplastic; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lymphoma, B-Cell; Methylation; Protein Binding; Protein Interaction Domains and Motifs; Proteolysis; Signal Transduction; Transcription, Genetic | 2022 |
Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.
Topics: 3' Untranslated Regions; Acetylation; Chromatin Immunoprecipitation Sequencing; CREB-Binding Protein; Cyclin D1; Down-Regulation; E1A-Associated p300 Protein; Gene Silencing; Genes, Tumor Suppressor; Histone Deacetylases; Histones; Humans; Lymphoma, B-Cell; Methylation; MicroRNAs; Promoter Regions, Genetic; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-myc | 2020 |
A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Topics: Animals; B-Lymphocytes; Blotting, Western; Bone Marrow Cells; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Flow Cytometry; Gene Expression Profiling; Histones; Humans; Kaplan-Meier Estimate; Lymphoma; Lymphoma, B-Cell; Lysine; Male; Methylation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Polycomb Repressive Complex 2; Proto-Oncogene Proteins c-myc; Spleen | 2014 |
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
Topics: Animals; B-Lymphocytes; Carcinogenesis; Cell Line, Tumor; Disease Progression; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Code; Humans; Immunoblotting; Lymphoma, B-Cell; Melanocytes; Melanoma; Methylation; Mice; Monomeric GTP-Binding Proteins; Mutation; Neoplasm Transplantation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Real-Time Polymerase Chain Reaction; Tumor Suppressor Protein p53 | 2016 |
Methylation analysis of the imprinted DLK1-GTL2 domain supports the random parental origin of the IGH-involving del(14q) in B-cell malignancies.
Topics: Alleles; Base Sequence; Calcium-Binding Proteins; Chromosomes, Human, Pair 14; Female; Genes, Immunoglobulin Heavy Chain; Humans; Intercellular Signaling Peptides and Proteins; Leukemia, B-Cell; Lymphoma, B-Cell; Male; Membrane Proteins; Methylation; Parents; Proteins; RNA, Long Noncoding | 2009 |
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.
Topics: Catalysis; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Histones; Humans; Kinetics; Lymphoma, B-Cell; Lysine; Methylation; Point Mutation; Polycomb Repressive Complex 2; Transcription Factors | 2010 |
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).
Topics: Alanine; Amino Acid Sequence; Base Sequence; Binding Sites; Cell Line, Tumor; DNA Mutational Analysis; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Glycine; Heterozygote; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lymphoma, B-Cell; Lysine; Methylation; Molecular Sequence Data; Mutant Proteins; Mutation; Polycomb Repressive Complex 2; Substrate Specificity; Transcription Factors | 2012 |
The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma.
Topics: Cell Line, Tumor; Collagen; CpG Islands; Gene Expression Regulation; Gene Silencing; Humans; Lymphoma, B-Cell; Methylation; Procollagen-Proline Dioxygenase | 2012 |
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.
Topics: Animals; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Cloning, Molecular; DNA End-Joining Repair; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lymphoma, B-Cell; Methylation; Mice; Tumor Suppressor Protein p53 | 2013 |
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.
Topics: Animals; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Gene Silencing; Histone Deacetylases; Histones; Humans; Lymphoma, B-Cell; Methylation; Mice; MicroRNAs; Polycomb Repressive Complex 2; Proto-Oncogene Proteins c-myc | 2012 |
The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours.
Topics: Apoptosis; Chronic Disease; Flow Cytometry; Glutathione; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Methylation; Organoselenium Compounds; Tumor Cells, Cultured | 2006 |
Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignancies.
Topics: Adult; Antigens, Viral; Azacitidine; Base Sequence; Burkitt Lymphoma; Decitabine; DNA-Binding Proteins; DNA, Neoplasm; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunodominant Epitopes; Lymphoma, B-Cell; Methylation; Molecular Sequence Data; Polymerase Chain Reaction; Tumor Cells, Cultured; Tumor Virus Infections; Viral Matrix Proteins; Virus Activation | 1995 |
A mutated promoter of a human Ig V lambda gene segment is associated with reduced germ-line transcription and a low frequency of rearrangement.
Topics: Amino Acid Sequence; Antibody Diversity; Base Sequence; DNA Mutational Analysis; Gene Expression Regulation; Gene Rearrangement, B-Lymphocyte, Light Chain; Genes, Immunoglobulin; Humans; Immunoglobulin Light Chains; Immunoglobulin Variable Region; Lymphoma, B-Cell; Methylation; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Sequence Homology, Nucleic Acid; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Differential induction of Egr-1 expression in WEHI-231 sublines does not correlate with apoptosis.
Topics: Animals; Antibodies, Anti-Idiotypic; Apoptosis; DNA-Binding Proteins; Early Growth Response Protein 1; Gene Expression Regulation, Neoplastic; Immediate-Early Proteins; Lymphoma, B-Cell; Methylation; Mice; Rabbits; Rats; Transcription Factors; Tumor Cells, Cultured | 1993 |
CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Topics: 5-Methylcytosine; Anemia, Aplastic; Burkitt Lymphoma; CpG Islands; Cytosine; DNA (Cytosine-5-)-Methyltransferases; DNA-Binding Proteins; DNA, Neoplasm; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Ghana; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Immunocompromised Host; Immunodominant Epitopes; Immunologic Surveillance; Lymphoma, B-Cell; Methylation; Neoplasm Proteins; Promoter Regions, Genetic; Tumor Virus Infections; Virus Latency | 1996 |
Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.
Topics: Burkitt Lymphoma; Carcinoma; Cell Line; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunosuppression Therapy; Lymphoma; Lymphoma, B-Cell; Methylation; Models, Genetic; Nasopharyngeal Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic; Tumor Cells, Cultured | 1999 |
Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.
Topics: Cell Cycle Proteins; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p27; Gene Deletion; Gene Silencing; Genes, p16; Genes, p53; Humans; Lymphoma, B-Cell; Methylation; Mutation; Promoter Regions, Genetic; Survival Analysis; Tumor Suppressor Proteins | 2001 |
Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability.
Topics: Aneuploidy; Animals; Chromosome Segregation; Fibroblasts; Gene Targeting; Genome; Germ Cells; Heterochromatin; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Hypogonadism; Lymphoma, B-Cell; Male; Mammals; Meiosis; Methylation; Methyltransferases; Mice; Mice, Knockout; Mice, Mutant Strains; Mutagenesis; Protein Methyltransferases; Repressor Proteins; Sex Chromosome Aberrations; Spermatocytes; Spermatogenesis | 2001 |
Resistance to interferon-alpha in a mouse B-cell lymphoma involves DNA methylation.
Topics: Animals; Azacitidine; DNA; Drug Resistance; Ethyl Methanesulfonate; Interferon-alpha; Lymphoma, B-Cell; Methylation; Mice; Mutagenesis; Tumor Cells, Cultured | 1992 |
A novel NF-kappa B element within exon 1 of the murine c-myc gene.
Topics: Animals; Base Sequence; Binding Sites; Chloramphenicol O-Acetyltransferase; Cloning, Molecular; DNA, Neoplasm; Exons; Genes, myc; Lymphoma, B-Cell; Methylation; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; NF-kappa B; Oligodeoxyribonucleotides; Restriction Mapping; Transfection; Tumor Cells, Cultured | 1992 |